Approval · Notice of Compliance 14675 · 2013
MENVEO: Notice of Compliance 14675
Issued August 21, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14675
- Date
- August 21, 2013
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MENVEO | Not yet assigned | — |
Medicinal ingredients
- MENINGOCOCCAL GROUP A OLIGOSACCHARIDE 10 MCG per 0.5ML
- MENINGOCOCCAL GROUP C OLIGOSACCHARIDE 5 MCG per 0.5ML
- MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE 5 MCG per 0.5ML
- MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE 5 MCG per 0.5ML